Communiqués Evofem Biosciences, Inc.

Actions

EVFM

US30048L3024

Produits pharmaceutiques

Temps Différé OTC Markets Autres places de cotation 17:07:00 03/08/2026			Varia. 5j.	Varia. 1 janv.
0,007500 ^USD	+7,14%		-5,06%	-21,05%

01/07	HUB Cyber Security acquiert des obligations convertibles d'Evofem et réduit ses effectifs	MT
15/05	Evofem Biosciences, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

23/07	Evofem Biosciences Celebrates Shipment of Its 500,000th Unit of PHEXX®, Representing Hormone-Free Protection from Unintended Pregnancy for 6 Million Acts of Sex	BU
18/05	Evofem Reports First Quarter 2026 Financial Results and Provides Business Update	BU
27/04	Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa	BU
11/03	Evofem Reports Fifth Consecutive Year of Net Sales Growth	BU
21/11	Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE	PR
13/11	Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update	PR
11/11	Evofem Biosciences : EVFM Investor Presentation Nov 2025	PU
01/10/25	Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates	PR
12/09/25	EVFM Investor Presentation: 12 September 2025	PU
09/09/25	Evofem Biosciences : Special Meeting of Stockholders	PU
05/09/25	Evofem Biosciences : EVFM Corporate Update 5 September 2025	PU
19/08/25	FDA Orange Book Lists New U.S. Patent for SOLOSEC, Evofem Biosciences' "One and Done" Oral Treatment for Bacterial Vaginosis and Trichomoniasis	PR
14/08/25	Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update	PR
30/07/25	Evofem Biosciences : AditXt Weekly Update 6.6.2025 - Transcript	PU
23/06/25	Evofem Biosciences : EVFM Corporate Update 23 June 2025	PU
23/06/25	Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store	PR
28/05/25	Evofem Biosciences : EVFM Corporate Overview 28 May 2025	PU
21/05/25	Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1	PR
15/05/25	Evofem Reports First Quarter 2025 Financial Results and Provides Business Update	PR
02/05/25	Evofem Biosciences : EVFM Corporate Overview 01 May, 2025	PU
21/04/25	Evofem Biosciences : EVFM Presentation at Emerging Growth Conference April 2025	PU
18/04/25	Evofem Biosciences : EVFM Corporate Overview April 9, 2025	PU
14/04/25	Evofem Biosciences to Present at Emerging Growth Conference	PR
24/03/25	Evofem Biosciences : Investor Presentation March 2025	PU
26/02/25	Evofem Biosciences : EVFM Investor Presentation February 2025	PU